AFT Pharmaceuticals Limited (NZE:AFT)
New Zealand flag New Zealand · Delayed Price · Currency is NZD
3.360
+0.010 (0.30%)
Apr 2, 2026, 5:00 PM NZST

AFT Pharmaceuticals Ratios and Metrics

Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
352282328363378518
Market Cap Growth
31.76%-14.06%-9.54%-4.00%-26.99%46.56%
Enterprise Value
377305363395414556
Last Close Price
3.362.673.093.413.564.88
PE Ratio
20.7723.5821.0334.0619.0468.17
Forward PE
22.4816.7919.4119.1218.4330.80
PS Ratio
1.491.361.682.322.904.58
PB Ratio
3.602.913.744.956.0714.15
P/TBV Ratio
9.093.364.476.358.1624.65
P/FCF Ratio
38.7021.8811.4231.7427.34787.96
P/OCF Ratio
37.8921.4111.3731.2026.71690.25
PEG Ratio
0.620.820.541.610.38-
EV/Sales Ratio
1.601.471.862.523.184.92
EV/EBITDA Ratio
14.4616.9214.7419.8920.0450.70
EV/EBIT Ratio
15.5917.2714.9820.1020.3151.93
EV/FCF Ratio
41.4123.6412.6334.5829.96846.29
Debt / Equity Ratio
0.390.310.370.520.651.15
Debt / EBITDA Ratio
1.451.591.271.851.903.61
Debt / FCF Ratio
4.162.331.123.332.9364.26
Net Debt / Equity Ratio
0.260.200.230.450.521.07
Net Debt / EBITDA Ratio
1.021.050.821.681.583.56
Net Debt / FCF Ratio
2.831.470.702.912.3659.37
Asset Turnover
1.481.241.251.141.121.18
Inventory Turnover
2.482.382.342.212.042.28
Quick Ratio
0.691.251.151.121.301.01
Current Ratio
1.512.512.302.382.672.12
Return on Equity (ROE)
18.27%12.33%19.38%15.72%40.14%28.91%
Return on Assets (ROA)
9.46%6.58%9.67%8.93%10.96%6.97%
Return on Invested Capital (ROIC)
13.90%11.21%16.02%13.17%23.92%15.78%
Return on Capital Employed (ROCE)
24.00%13.90%20.30%18.20%20.70%14.70%
Earnings Yield
4.95%4.24%4.75%2.94%5.25%1.50%
FCF Yield
2.58%4.57%8.76%3.15%3.66%0.13%
Dividend Yield
0.54%0.67%0.52%0.32%--
Payout Ratio
10.82%14.03%7.39%--2.42%
Buyback Yield / Dilution
7.83%--0.02%-0.16%-1.34%-6.15%
Total Shareholder Return
8.36%0.67%0.50%0.16%-1.34%-6.15%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.